COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy.
作者信息
Bhardwaj Ankit, Roy Vandana
机构信息
Department of Pharmacology, ABVIMS and Dr. RML Hospital, New Delhi, India.
Department of Pharmacology, MAMC and LNJP Hospital, New Delhi, India.
出版信息
Indian J Pharmacol. 2021 Sep-Oct;53(5):415-416. doi: 10.4103/ijp.ijp_406_21.
Abstract
摘要
相似文献
1
COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy.
Indian J Pharmacol. 2021 Sep-Oct;53(5):415-416. doi: 10.4103/ijp.ijp_406_21.
2
Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
Indian J Pharmacol. 2021 Sep-Oct;53(5):417-419. doi: 10.4103/ijp.ijp_392_21.
3
Implications of the second wave of COVID-19 in India.
Lancet Respir Med. 2021 Sep;9(9):e93-e94. doi: 10.1016/S2213-2600(21)00312-X. Epub 2021 Jun 30.
4
Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
Int J Biol Macromol. 2021 Sep 30;187:988-998. doi: 10.1016/j.ijbiomac.2021.07.156. Epub 2021 Jul 27.
5
Update on mucormycosis pathogenesis.
Curr Opin Infect Dis. 2013 Dec;26(6):508-15. doi: 10.1097/QCO.0000000000000008.
6
Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis.
Lancet Infect Dis. 2021 Nov;21(11):1611. doi: 10.1016/S1473-3099(21)00582-X.
7
Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Indian J Pharmacol. 2021 Jul-Aug;53(4):317-327. doi: 10.4103/ijp.ijp_419_21.
8
Resolving the equation between mucormycosis and COVID-19 disease.
Mol Biol Rep. 2022 Apr;49(4):3349-3356. doi: 10.1007/s11033-021-07085-3. Epub 2022 Jan 22.
9
Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.
Mycoses. 2014 Dec;57 Suppl 3(0 3):13-7. doi: 10.1111/myc.12232. Epub 2014 Sep 1.
10
Role of Iron Chelators in Mucormycosis.
Indian J Pharmacol. 2021 Jul-Aug;53(4):261-263. doi: 10.4103/ijp.ijp_604_21.
引用本文的文献
1
Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated mucormycosis causing fungi.
PLoS One. 2023 Mar 30;18(3):e0279118. doi: 10.1371/journal.pone.0279118. eCollection 2023.
本文引用的文献
1
Relationship between serum ferritin and inflammatory biomarkers with insulin resistance in a Persian population with type 2 diabetes and healthy people.
Int J Food Sci Nutr. 2010 May;61(3):316-23. doi: 10.3109/09637480903555150.
2
Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management.
Infect Dis Clin North Am. 2006 Sep;20(3):581-607, vi. doi: 10.1016/j.idc.2006.06.003.
3
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.
J Clin Invest. 1993 May;91(5):1979-86. doi: 10.1172/JCI116419.
4
Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect.
Kidney Int. 1994 Mar;45(3):667-71. doi: 10.1038/ki.1994.89.
Zotero 插件